Hydrofarm Announces Third Quarter 2026 Results and Subsequent Elimination of Term Loan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Hydrofarm (Nasdaq: HYFM) reported third-quarter results and completed an October 2026 recapitalization that eliminated $109 million of Term Loan debt.
Quarterly sales fell 50.7% year over year to $14.5 million. Gross margin rose to 17.7% from 11.6%, while net loss narrowed to $7.8 million from $16.4 million. Adjusted EBITDA, a non-GAAP earnings measure, improved to negative $1.1 million from negative $4.4 million. Operating cash outflow was $7.5 million.
The July Aurora Peat Products sale brought $16 million in consideration, including a $5 million promissory note. October financing raised approximately $8.3 million gross. Former lenders received convertible preferred stock and warrants; Hydrofarm expects approximately 41.8 million common shares outstanding after the offering and preferred conversion. The company expects positive adjusted EBITDA in the next year.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointOctober recapitalization eliminated $109 million of Term Loan debt. 33× market cap
- Major pointOctober stock and warrant financing raised approximately $8.3 million in gross proceeds. 2.5× market cap
- Major pointAurora Peat Products sale generated $16 million consideration, including a $5 million promissory note, for debt and interest reduction. 4.9× market cap
- Moderate pointThird-quarter gross margin increased to 17.7% from 11.6% a year earlier.
- Moderate pointThird-quarter adjusted gross margin increased to 23.6% from 18.8% a year earlier.
- Moderate pointThird-quarter selling, general and administrative expense fell 51.4% to $8.0 million.
- Moderate pointThird-quarter net loss narrowed to $7.8 million, or $1.61 per diluted share, from $16.4 million, or $3.51.
- Moderate pointThird-quarter adjusted EBITDA improved to negative $1.1 million from negative $4.4 million a year earlier.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Hydrofarm expects to reach positive adjusted EBITDA in the next year.
5 minor points
- Minor pointThird-quarter adjusted selling, general and administrative expense fell 54.1% to $4.5 million.
- Minor point. Forward-looking: it has not happened yet and may not happen.Hydrofarm plans to expand its direct commercial sales channel, currently approximately one-third of its business.
- Minor pointNine-month net loss narrowed to $33.021 million from $47.636 million a year earlier.
- Minor pointNine-month selling, general and administrative expense fell to $28.585 million from $50.368 million.
- Minor pointNine-month adjusted selling, general and administrative expense fell to $19.293 million from $30.669 million.
Negative
- Major pointRecapitalization issued $27.5 million convertible preferred stock to former lenders, convertible at a stated $1.00 per share. 8.4× market cap
- Major pointFormer lenders received warrants for 27.5 million common shares at $0.78 per share, adding potential dilution.
- Major point. Forward-looking: it has not happened yet and may not happen.Offering issued common stock and warrants; Hydrofarm expects approximately 41.8 million common shares after offering and preferred conversion.
- Major pointThird-quarter sales declined 50.7% to $14.5 million amid brand discontinuations, Canadian divestitures and constrained working capital.
- Moderate pointThird-quarter gross profit declined to $2.6 million from $3.4 million a year earlier.
- Moderate pointThird-quarter adjusted gross profit declined to $3.4 million from $5.5 million a year earlier.
- Moderate pointThird-quarter operating cash outflow increased to $7.5 million from less than $0.1 million a year earlier.
- Moderate pointCash and restricted cash fell to $3.9 million at September 30, 2026, from $6.6 million at June 30.
- Moderate pointSeptember 30 obligations included $7.5 million finance leases and $0.1 million other debt.
- Moderate pointNine-month interest expense increased to $12.704 million from $10.099 million a year earlier.
- Moderate pointStockholders’ deficit widened to $93.885 million at September 30, 2026, from $63.296 million at December 31, 2025.
4 minor points
- Minor pointThird-quarter free cash outflow increased to $7.5 million from $0.2 million a year earlier.
- Minor pointNine-month sales declined to $66.190 million from $109.129 million a year earlier.
- Minor pointNine-month gross profit declined to $7.029 million from $13.080 million; gross margin fell to 10.6% from 12.0%.
- Minor pointNine-month adjusted gross profit fell to $12.571 million from $21.571 million; adjusted margin fell to 19.0% from 19.8%.
Key Figures
- Net sales
- $14.5 million vs. $29.4 million (-50.7%)
- Third quarter 2026 vs. prior-year period
- Gross profit margin
- 17.7% vs. 11.6%
- Third quarter 2026 vs. prior-year period
- Adjusted gross profit margin
- 23.6% vs. 18.8%
- Third quarter 2026 vs. prior-year period
- Net loss
- $7.8 million vs. $16.4 million
- Third quarter 2026 vs. prior-year period
- Adjusted EBITDA
- $(1.1) million vs. $(4.4) million
- Third quarter 2026 vs. prior-year period
- Free cash flow
- $(7.5) million vs. $(0.2) million
- Third quarter 2026 vs. prior-year period
- Term Loan debt eliminated
- $109 million
- October 2026 recapitalization
- Gross proceeds
- Approximately $8.3 million
- Registered direct offering and concurrent private placement
Previous Earnings Reports
-
Sales fell while gross margin and Adjusted EBITDA improved.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
adjusted ebitda financial
non-gaap measures financial
registered direct offering financial
convertible preferred stock financial
warrants financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
SHOEMAKERSVILLE, Pa., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded supplies and equipment for controlled environment agriculture ("CEA"), today announced financial results for its third quarter ended September 30, 2026.
Third Quarter Events and Comparison vs. Prior Year Period:
- Net sales decreased to
$14.5 million compared to$29.4 million . - Gross Profit Margin increased to
17.7% of net sales compared to11.6% . - Adjusted Gross Profit Margin(1) increased to
23.6% of net sales compared to18.8% . - SG&A expense and Adjusted SG&A(1) expense decreased by
51.4% and54.1% , respectively. - Net loss decreased to
$7.8 million compared to$16.4 million . - Adjusted EBITDA(1) of
$(1.1) million compared to$(4.4) million . - Cash used in operating activities and Free Cash Flow(1) were each
$(7.5) million which included a$4.4 million cash interest payment on the now terminated Term Loan debt facility, and$2.8 million of debt and restructuring related payments; compared to cash used in operating activities and Free Cash Flow(1) of less than$(0.1) million and$(0.2) million , respectively.
(1)Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.
Hydrofarm also recently completed the following transactions:
- Sold Aurora Peat Products in the third quarter of 2026 for
$16 million gross proceeds, reducing debt and simplifying operating footprint. - Subsequent to the third quarter, Hydrofarm recapitalized the business, eliminating
$109 million of Term Loan debt and raising$8.3 million in gross proceeds.
"In the third quarter, our higher margin proprietary brand sales exceeded two-thirds of total sales and contributed to our highest Adjusted Gross Profit margin percentage since Q3 2024. We also reduced Adjusted SG&A expense by over
Third Quarter 2026 Financial Results
Net sales decreased
Gross Profit decreased to
Selling, general and administrative ("SG&A") expense improved to
Net loss was
Adjusted EBITDA(1) improved to
Balance Sheet, Liquidity, and Aurora Peat Products Sale
As of September 30, 2026, the Company had
As previously disclosed, on February 4, 2026, the Company elected to defer making the interest payment on its Term Loan, resulting in an event of default. The Term Loan was classified as current debt on the September 30, 2026 balance sheet. On July 31, 2026, the Company sold its Aurora Peat Products business in Canada for total consideration of
October 2026 Recapitalization
In October 2026, the Company completed its recapitalization, whereby the
(1)Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.
About Hydrofarm Holdings Group, Inc.
Hydrofarm is a leading independent manufacturer and distributor of supplies and equipment for controlled environment agriculture, including plant nutrition, growing media, horticultural lighting and climate control solutions, spanning a portfolio of proprietary and select partner brands. The Company manufactures its proprietary plant nutrition and growing media brands in Eugene, Oregon, and, through its logistics services platform, provides third-party warehousing, fulfillment and distribution services across a wide range of industries. For nearly 50 years, Hydrofarm has helped growers make growing easier and more productive. The Company’s mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency and speed.
Cautionary Note Regarding Forward-Looking Statements
Statements contained in this press release, other than statements of historical fact, which address activities, events and developments that the Company expects or anticipates will or may occur in the future, including, but not limited to, information regarding the future economic performance and financial condition of the Company, including its return to positive Adjusted EBITDA, the expansion of the direct commercial sales channel, the plans and objectives of the Company’s management, and the Company’s assumptions regarding such performance and plans are “forward-looking statements” within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” or other similar words or phrases. Actual results could differ materially from the forward-looking information in this release due to a variety of factors, including, but not limited to:
The Company's ability to continue as a going concern; The Company's ability to effect strategic changes to its business including the expansion of the logistics services business and direct commercial sales channel; The market in which the Company operates has been substantially adversely impacted by conditions of the agricultural and cannabis industries, including oversupply and decreasing prices of the products the Company's end customers sell, which, in turn, has materially adversely impacted the Company's sales and other results of operations and which may continue to do so in the future; If industry conditions worsen or are sustained for a lengthy period, the Company could be forced to take additional impairment charges and/or inventory and accounts receivable reserves, which could be substantial, and, ultimately, the Company may face liquidity challenges; The Company's ability to resolve claims from unsecured creditors in the ordinary course of business; The Company’s future debt facilities may limit the operation of the Company’s business including restricting its ability to sell products directly to the cannabis industry; Although equity financing may be available, the Company's current stock prices are at depressed levels and any such financing would be dilutive; Interruptions in the Company's supply chain could adversely impact expected sales growth and operations; Increased prices and inflation could adversely impact the Company's performance and financial results; Global political and economic conditions including the imposition of potential tariffs could increase the costs of the Company's products and adversely impact the competitiveness of the Company's products and the Company's financial results; The Company may be unable to regain compliance and continue to meet the continued listing standards of Nasdaq; The Company's restructuring activities may increase our expenses and cash expenditures, and may not have the intended cost saving effects; The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenues; Certain of the Company’s products may be purchased for use in new or emerging industries or segments, including the cannabis industry, and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative and enforcement approaches, and consumer perceptions which may adversely impact the market for the Company’s products; The market for the Company’s products has been impacted by conditions impacting its customers, including related crop prices, climate change, and other factors impacting growers; Compliance with government laws and regulations including environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; Damage to the Company’s reputation or the reputation of its products or products it markets on behalf of third parties could have an adverse effect on its business; If the Company is unable to effectively execute its e-commerce business, its reputation and operating results may be harmed; The Company’s operations may be impaired if its information technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack; The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; Acquisitions, other strategic alliances and investments could result in operating and integration difficulties, dilution and other harmful consequences that may adversely impact the Company’s business and results of operations. Additional detailed information concerning a number of the important factors that could cause actual results to differ materially from the forward-looking information contained in this release is readily available in the Company’s annual, quarterly and other reports. The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments except as otherwise required by law.
| Hydrofarm Holdings Group, Inc. | ||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | ||||||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net sales | $ | 14,455 | $ | 29,350 | $ | 66,190 | $ | 109,129 | ||||||||
| Cost of goods sold | 11,897 | 25,941 | 59,161 | 96,049 | ||||||||||||
| Gross profit | 2,558 | 3,409 | 7,029 | 13,080 | ||||||||||||
| Operating expenses: | | | | | ||||||||||||
| Selling, general and administrative | 7,955 | 16,365 | 28,585 | 50,368 | ||||||||||||
| Gain on sale of business | (1,491 | ) | — | (1,491 | ) | — | ||||||||||
| Loss from operations | (3,906 | ) | (12,956 | ) | (20,065 | ) | (37,288 | ) | ||||||||
| Interest expense | (3,385 | ) | (3,331 | ) | (12,704 | ) | (10,099 | ) | ||||||||
| Other (expense) income, net | (367 | ) | 22 | (464 | ) | (140 | ) | |||||||||
| Loss before tax | (7,658 | ) | (16,265 | ) | (33,233 | ) | (47,527 | ) | ||||||||
| Income tax (expense) benefit | (121 | ) | (125 | ) | 212 | (109 | ) | |||||||||
| Net loss | $ | (7,779 | ) | $ | (16,390 | ) | $ | (33,021 | ) | $ | (47,636 | ) | ||||
| | | | | |||||||||||||
| Net loss per share: | | | | | ||||||||||||
| Basic | $ | (1.61 | ) | $ | (3.51 | ) | $ | (6.90 | ) | $ | (10.26 | ) | ||||
| Diluted | $ | (1.61 | ) | $ | (3.51 | ) | $ | (6.90 | ) | $ | (10.26 | ) | ||||
| Weighted-average shares of common stock outstanding: | | | | | ||||||||||||
| Basic | 4,817,377 | 4,663,422 | 4,786,133 | 4,641,522 | ||||||||||||
| Diluted | 4,817,377 | 4,663,422 | 4,786,133 | 4,641,522 | ||||||||||||
| Hydrofarm Holdings Group, Inc. | ||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) | ||||||||
| (In thousands, except share and per share amounts) | ||||||||
| September 30, 2026 | December 31, 2025 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 3,421 | $ | 6,309 | ||||
| Restricted cash | 460 | — | ||||||
| Accounts receivable, net | 7,408 | 8,186 | ||||||
| Inventories | 19,080 | 33,324 | ||||||
| Prepaid expenses and other current assets | 2,167 | 3,622 | ||||||
| Total current assets | 32,536 | 51,441 | ||||||
| Property, plant and equipment, net | 12,212 | 30,334 | ||||||
| Operating lease right-of-use assets | 27,692 | 37,765 | ||||||
| Intangible assets, net | 2,801 | 2,801 | ||||||
| Other assets | 821 | 1,463 | ||||||
| Total assets | $ | 76,062 | $ | 123,804 | ||||
| Liabilities and stockholders’ deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 10,166 | $ | 9,752 | ||||
| Accrued expenses and other current liabilities | 10,068 | 7,688 | ||||||
| Deferred revenue | 727 | 2,742 | ||||||
| Current portion of operating lease liabilities | 7,562 | 7,543 | ||||||
| Current portion of finance lease liabilities | 471 | 455 | ||||||
| Current portion of long-term debt | 108,898 | 111,853 | ||||||
| Total current liabilities | 137,892 | 140,033 | ||||||
| Long-term operating lease liabilities | 24,728 | 32,800 | ||||||
| Long-term finance lease liabilities | 7,021 | 7,381 | ||||||
| Long-term debt | 33 | 50 | ||||||
| Deferred tax liabilities | — | 2,130 | ||||||
| Other long-term liabilities | 273 | 4,706 | ||||||
| Total liabilities | 169,947 | 187,100 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ deficit | ||||||||
| Common stock ( | — | — | ||||||
| Additional paid-in capital | 791,595 | 791,227 | ||||||
| Accumulated other comprehensive loss | (5,208 | ) | (7,272 | ) | ||||
| Accumulated deficit | (880,272 | ) | (847,251 | ) | ||||
| Total stockholders’ deficit | (93,885 | ) | (63,296 | ) | ||||
| Total liabilities and stockholders’ deficit | $ | 76,062 | $ | 123,804 | ||||
| Hydrofarm Holdings Group, Inc. | ||||||||||||||||
| RECONCILIATION OF NON-GAAP MEASURES | ||||||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Reconciliation of Adjusted Gross Profit: | | | | | ||||||||||||
| Gross Profit (GAAP) | $ | 2,558 | $ | 3,409 | $ | 7,029 | $ | 13,080 | ||||||||
| Depreciation, depletion and amortization | 736 | 1,346 | 2,673 | 4,075 | ||||||||||||
| Restructuring expenses1 | 102 | 753 | 2,859 | 4,416 | ||||||||||||
| Other | 10 | — | 10 | — | ||||||||||||
| Adjusted Gross Profit (Non-GAAP) | $ | 3,406 | $ | 5,508 | $ | 12,571 | $ | 21,571 | ||||||||
| | | | | |||||||||||||
| As a percent of net sales: | | | | | ||||||||||||
| Gross Profit Margin (GAAP) | 17.7 | % | 11.6 | % | 10.6 | % | 12.0 | % | ||||||||
| Adjusted Gross Profit Margin (Non-GAAP) | 23.6 | % | 18.8 | % | 19.0 | % | 19.8 | % | ||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Reconciliation of Adjusted SG&A: | | | | | ||||||||||||
| Selling, general and administrative (GAAP) | $ | 7,955 | $ | 16,365 | $ | 28,585 | $ | 50,368 | ||||||||
| Depreciation, depletion and amortization | 33 | 5,990 | 115 | 17,982 | ||||||||||||
| Restructuring expenses1 | 758 | 142 | 3,863 | 162 | ||||||||||||
| Other2 | 1,243 | 130 | 1,325 | 359 | ||||||||||||
| Stock-based compensation3 | 73 | 207 | 389 | 971 | ||||||||||||
| Debt transactions and strategic alternatives4 | 1,306 | 10 | 3,600 | 225 | ||||||||||||
| Adjusted SG&A (Non-GAAP) | $ | 4,542 | $ | 9,886 | $ | 19,293 | $ | 30,669 | ||||||||
| | | | | |||||||||||||
| As a percent of net sales: | | | | | ||||||||||||
| SG&A (GAAP) | 55.0 | % | 55.8 | % | 43.2 | % | 46.2 | % | ||||||||
| Adjusted SG&A (Non-GAAP) | 31.4 | % | 33.7 | % | 29.1 | % | 28.1 | % | ||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Reconciliation of Adjusted EBITDA: | | | | | ||||||||||||
| Net loss (GAAP) | $ | (7,779 | ) | $ | (16,390 | ) | $ | (33,021 | ) | $ | (47,636 | ) | ||||
| Interest expense | 3,385 | 3,331 | 12,704 | 10,099 | ||||||||||||
| Income tax expense (benefit) | 121 | 125 | (212 | ) | 109 | |||||||||||
| Depreciation, depletion and amortization | 769 | 7,336 | 2,788 | 22,057 | ||||||||||||
| Restructuring expenses1 | 860 | 895 | 6,722 | 4,578 | ||||||||||||
| Other2 | 1,253 | 130 | 1,335 | 359 | ||||||||||||
| Stock-based compensation3 | 73 | 207 | 389 | 971 | ||||||||||||
| Debt transactions and strategic alternatives4 | 1,306 | 10 | 3,600 | 225 | ||||||||||||
| Gain on sale of business5 | (1,491 | ) | — | (1,491 | ) | — | ||||||||||
| Other expense (income), net6 | 367 | (22 | ) | 464 | 140 | |||||||||||
| Adjusted EBITDA (Non-GAAP) | $ | (1,136 | ) | $ | (4,378 | ) | $ | (6,722 | ) | $ | (9,098 | ) | ||||
| | | | | |||||||||||||
| As a percent of net sales: | | | | | ||||||||||||
| Net loss (GAAP) | (53.8 | )% | (55.8 | )% | (49.9 | )% | (43.7 | )% | ||||||||
| Adjusted EBITDA (Non-GAAP) | (7.9 | )% | (14.9 | )% | (10.2 | )% | (8.3 | )% | ||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Reconciliation of Free Cash Flow: | | | | | ||||||||||||
| Net cash from (used in) operating activities (GAAP): | $ | (7,486 | ) | $ | (37 | ) | $ | (8,193 | ) | $ | (10,084 | ) | ||||
| Capital expenditures of Property, plant and equipment (GAAP) | (9 | ) | (170 | ) | (89 | ) | (695 | ) | ||||||||
| Free Cash Flow (Non-GAAP): | $ | (7,495 | ) | $ | (207 | ) | $ | (8,282 | ) | $ | (10,779 | ) | ||||
Notes to GAAP to Non-GAAP reconciliations presented above (Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA, and Free Cash Flow):
- For the three and nine months ended September 30, 2026, non-cash restructuring expenses were primarily associated with the write-down of certain right of use assets which were recorded in selling, general and administrative expenses, and inventory write-downs which were recorded in cost of goods sold. Cash charges were primarily comprised of costs incurred to relocate and terminate certain facilities. For the three and nine months ended September 30, 2025, Restructuring expenses primarily related to non-cash inventory markdowns.
- For the nine months ended September 30, 2026, other charges were primarily comprised of accrued legal charges for certain matters. For the nine months ended September 30, 2025, other charges primarily related to legal costs related to the 1-for-10 reverse stock split effected on February 12, 2025, as well as severance charges.
- Includes stock-based compensation and related employer payroll taxes on stock-based compensation for the periods presented.
- For the three and nine months ended September 30, 2026, debt transactions and strategic alternatives charges include legal and advisory services associated with debt transactions, including the forbearance agreement. For the three and nine months ended September 30, 2025, debt transactions and strategic alternatives charges include consulting, transaction services and legal fees for potential acquisitions, divestitures, or strategic combinations. Such amounts were previously presented in the line item titled “Acquisition and integration expenses.”
- For the three and nine months ended September 30, 2026, gain on sale of business reflects the gain recorded for the sale of our Aurora Peat Products business.
- For the three and nine months ended September 30, 2026 and 2025, other expense (income), net related primarily to foreign currency exchange rate gains and losses and other non-operating income and expenses.
Non-GAAP Financial Measures
We report our financial results in accordance with generally accepted accounting principles in the U.S. (“GAAP”). Management believes that certain non-GAAP financial measures provide investors with additional useful information in evaluating our performance and that excluding certain items that may vary substantially in frequency and magnitude period-to-period from net loss provides useful supplemental measures that assist in evaluating our ability to generate earnings and to more readily compare these metrics between past and future periods. These non-GAAP financial measures may be different than similarly titled measures used by other companies.
To supplement our condensed consolidated financial statements which are prepared in accordance with GAAP, we use "Adjusted EBITDA", "Adjusted Gross Profit", "Adjusted SG&A", "Free Cash Flow", "Net Debt", and "Liquidity" which are non-GAAP financial measures. We also present certain of these non-GAAP metrics as a percentage of net sales. Our non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. There are several limitations related to the use of our non-GAAP financial measures as compared to the closest comparable GAAP measures.
We define Adjusted EBITDA (non-GAAP) as net loss (GAAP) excluding interest expense, income taxes, depreciation, depletion and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, impairments, severance, loss on asset disposition, other income/expense, net, gain on sale of business, and other non-cash, unusual and/or infrequent costs (i.e., debt transactions and strategic alternatives), which we do not consider in our evaluation of ongoing operating performance.
We define Adjusted EBITDA (non-GAAP) as a percent of net sales as Adjusted EBITDA (as defined above) divided by net sales in the respective period.
We define Adjusted Gross Profit (non-GAAP) as Gross Profit (GAAP) excluding depreciation, depletion, and amortization, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs, which we do not consider in our evaluation of ongoing operating performance.
We define Adjusted Gross Profit Margin (non-GAAP) as a percent of net sales as Adjusted Gross Profit (as defined above) divided by net sales in the respective period.
We define Adjusted SG&A (non-GAAP) as SG&A (GAAP) excluding depreciation, depletion, and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs (i.e., acquisition and integration expenses), which we do not consider in our evaluation of ongoing operating performance.
We define Adjusted SG&A (non-GAAP) as a percent of net sales as Adjusted SG&A (as defined above) divided by net sales in the respective period.
We define Free Cash Flow (non-GAAP) as Net cash from (used in) operating activities less capital expenditures for property, plant and equipment. We believe this provides additional insight into the Company's ability to generate cash and maintain liquidity. However, Free Cash Flow does not represent funds available for investment or other discretionary uses since it does not deduct cash used to service our debt or other cash flows from financing activities or investing activities.
We define Liquidity as total cash, cash equivalents and restricted cash, if applicable.
We define Net Debt as total debt principal outstanding plus finance lease liabilities and other debt, less cash, cash equivalents and restricted cash, if applicable.

Contacts: Investor Contact ir@hydrofarm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Hydrofarm's third-quarter 2026 earnings results?
Hydrofarm reported $14.5 million in sales and a $7.8 million net loss for the quarter ended September 30, 2026. Sales fell 50.7% year over year, while net loss narrowed from $16.4 million. Adjusted EBITDA improved to negative $1.1 million from negative $4.4 million.
Why did Hydrofarm use $7.5 million of operating cash in the third quarter of 2026?
Hydrofarm's $7.5 million operating cash outflow included $4.4 million in cash interest and $2.8 million in payments related to debt and strategic alternatives transactions, and restructuring. The interest payment was connected with the Aurora Peat Products sale and related to the now-terminated Term Loan facility.